{"brief_title": "A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone", "brief_summary": "This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.", "condition": "Turner Syndrome", "study_pop": "\n      ", "sampling_method": "Non-Probability Sample", "criteria": "Inclusion Criteria: - Are girls with Turner syndrome who are being or will be treated with Nutropin, Nutropin AQ, or Protropin - Are willing to keep follow-up appointments throughout study participation - Are girls with Turner syndrome who have submitted Form 4 upon discontinuation and may also submit Form 9 Exclusion Criteria: - Have Noonan syndrome - Subjects treated within the last 6 months with a non-Genentech GH preparation - Have closed epiphyses prior to NCGS enrollment - Have active neoplasia", "gender": "Female", "minimum_age": "N/A", "maximum_age": "17 Years", "healthy_volunteers": "No", "id": "NCT00097552.xml"}